Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice

BACKGROUND: The risk of device thrombosis and device-oriented clinical outcomes with bioresorbable vascular scaffold (BVS) was reported to be significantly higher than with contemporary drug-eluting stents (DESs). However, optimal device implantation may improve clinical outcomes in patients receivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joo Myung, Joh, Hyun Sung, Choi, Ki Hong, Hong, David, Park, Taek Kyu, Yang, Jeong Hoon, Song, Young Bin, Choi, Jin-Ho, Choi, Seung-Hyuk, Jeong, Jin-Ok, Lee, Jong-Young, Choi, Young Jin, Chae, Jei-Keon, Hur, Seung-Ho, Bae, Jang-Whan, Oh, Ju-Hyeon, Chun, Kook-Jin, Kim, Hyun-Joong, Cho, Byung Ryul, Shin, Doosup, Lee, Seung Hun, Hwang, Doyeon, Lee, Hyun-Jong, Jang, Ho-Jun, Kim, Hyun Kuk, Ha, Sang Jin, Shin, Eun-Seok, Doh, Joon-Hyung, Hahn, Joo-Yong, Gwon, Hyeon-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902667/
https://www.ncbi.nlm.nih.gov/pubmed/36747363
http://dx.doi.org/10.3346/jkms.2023.38.e34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902667/
https://www.ncbi.nlm.nih.gov/pubmed/36747363
http://dx.doi.org/10.3346/jkms.2023.38.e34

Ejemplares similares